PharVision Advisers’s Avnet AVT Stock Holding History

PharVision Advisers’s Portfolio AVT Stock Details AVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,503	Closed	-$217K	–	147
2025 Q4	$217K	Buy	+4,503	New	+$221K	0.11%	496

Other funds holding AVT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Greenhaven Associates Purchase, New York $8.66B AUM 17.37% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PharVision Advisers's AVT Position: Q1 2026 in Review

PharVision Advisers sold out of Avnet (AVT) in Q1 2026, closing a stake of 4,503 shares — an estimated $217K sold.

PharVision Advisers first reported a position in AVT in Q4 2025 and held it in 1 quarter. The position peaked at $217K in Q4 2025. 445 funds tracked by Wall St. Rank hold AVT as of Q1 2026.

PharVision Advisers reported no remaining Avnet position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 4,503 Avnet shares in Q1 2026, an estimated $217K.
PharVision Advisers first reported a position in Avnet in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Avnet position peaked at $217K in Q4 2025.
445 funds tracked by Wall St. Rank held Avnet as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.